BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9288434)

  • 1. Spiramycin-associated acute dystonia during neuroleptic treatment.
    Benazzi F
    Can J Psychiatry; 1997 Aug; 42(6):665-6. PubMed ID: 9288434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Tardive dystonia--a case report on therapy and metaphylaxis].
    Genz A
    Psychiatr Neurol Med Psychol (Leipz); 1988 May; 40(5):264-8. PubMed ID: 2905065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
    Dencker SJ
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tardive dystonia: a rare side effect after long-term neuroleptic treatment].
    Bartels M; Riffel B; Stöhr M
    Nervenarzt; 1982 Nov; 53(11):674-6. PubMed ID: 6129578
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trial of a delayed-action neuroleptic, fluphenazine oenanthate (Moditen-retard, Squibb Lab.)].
    Haumonté MT; Hoerdt HP
    Ann Med Psychol (Paris); 1972 Feb; 1(2):277-83. PubMed ID: 5051257
    [No Abstract]   [Full Text] [Related]  

  • 7. Tardive dyskinesia and current dose of neuroleptic drugs.
    Kolakowska T; Williams AO; Ardern M
    Arch Gen Psychiatry; 1985 Sep; 42(9):925. PubMed ID: 2864034
    [No Abstract]   [Full Text] [Related]  

  • 8. Late-Onset Rhabdomyolysis Associated With an Intramuscular Injection of Fluphenazine Decanoate.
    Umino M; Kobayashi R; Nisijima K; Suda S
    Prim Care Companion CNS Disord; 2017 Sep; 19(5):. PubMed ID: 28972705
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rapid and megadose neuroleptic therapy. Critical review].
    de Girolamo G
    Minerva Psichiatr; 1985; 26(4):323-6. PubMed ID: 2869395
    [No Abstract]   [Full Text] [Related]  

  • 10. Antipsychotic drug side effects: their relationship to dose.
    Kane JM
    J Clin Psychiatry; 1985 May; 46(5 Pt 2):16-21. PubMed ID: 2859276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
    Liu PY; Wu PC; Chen CY; Chen YC
    Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome.
    Tofler IT; Ahmed B
    J Clin Psychopharmacol; 2003 Dec; 23(6):672-4. PubMed ID: 14624203
    [No Abstract]   [Full Text] [Related]  

  • 13. An unusual effect of ECT on drug-induced parkinsonism and tardive dystonia.
    Hanin B; Lerner Y; Srour N
    Convuls Ther; 1995 Dec; 11(4):271-4. PubMed ID: 8919580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haloperidol decanoate as a replacement for maintenance therapy with intramuscular fluphenazine decanoate in schizophrenia and other chronic psychoses.
    Roose K
    Acta Psychiatr Belg; 1982; 82(2):216-23. PubMed ID: 7180558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depot fluphenazine: risk/benefit ratio.
    Glazer WM
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):28-35. PubMed ID: 6370986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic dose reduction in persistently psychotic patients.
    Faraone SV; Green AI; Brown W; Yin P; Tsuang MT
    Hosp Community Psychiatry; 1989 Nov; 40(11):1193-5. PubMed ID: 2572532
    [No Abstract]   [Full Text] [Related]  

  • 17. Depot phenothiazine treatment in acute psychosis: a sequential comparative clinical study.
    Chien CP; Cole JO
    Am J Psychiatry; 1973 Jan; 130(1):13-8. PubMed ID: 4566388
    [No Abstract]   [Full Text] [Related]  

  • 18. The Pisa syndrome during maintenance antipsychotic therapy.
    Guy N; Raps A; Assael M
    Am J Psychiatry; 1986 Nov; 143(11):1492. PubMed ID: 2877586
    [No Abstract]   [Full Text] [Related]  

  • 19. Selection of neuroleptic dosage.
    Teicher MH; Baldessarini RJ
    Arch Gen Psychiatry; 1985 Jun; 42(6):636-7. PubMed ID: 2860885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treatment by Moditen Depot in outpatients' wards in the South Moravian Region (author's transl)].
    Rektor L; Blazek J
    Cesk Psychiatr; 1980; 76(6):369-75. PubMed ID: 7471277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.